Cite
MLA Citation
V. Bhagawati-Prasad et al.. “68 An audit of the use of first-line EGFR TKI treatment in NSCLC patients with EGFR activating mutations at the York Teaching Hospitals and Harrogate and District NHS Foundation Trust.” Lung cancer, vol. 91, n.d., pp. S24–S25. http://access.bl.uk/ark:/81055/vdc_100030532200.0x000016